2m 2m 2m 2m 2m 2m 2m
PRELUDE THERAP (PRLD)
NASDAQ
$3.66$0.00 (0.00%)
Price as of Jun 03, 2026 7:01 PM EDT- $254.5MMarket Cap
- 274.21%1-Year Change
- BiotechnologyIndustry
PRELUDE THERAP (PRLD)
$3.66$0.00 (0.00%)
PRLD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.66 | ||
Change | -$0.32 (-8.38%) | ||
Open | $3.49 | ||
High | $3.72 | ||
Low | $3.40 | ||
Previous Close | $3.50 | ||
Volume | 375,328 | ||
30-Day Average Volume | 390,015 | ||
1-Week Change | -14.43% | ||
1-Month Change | -25.53% | ||
1-Year Change | 274.21% | ||
3-Year Change | -38.49% | ||
5-Year Change | -88.99% | ||
Fundamentals | |||
Shares Outstanding | 64.9M | ||
Total Assets | $119.6M | ||
Market Cap | $254.5M | ||
Enterprise Value | $232.7M | ||
Period: QTR TTM FY | |||
Revenue | $4.6M | ||
Net Income | -$10.4M | ||
Free Cash Flow | -$21.7M | ||
EBIT | -$10.4M | ||
EBITDA | -$10.0M | ||
Net Working Capital | $42.9M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | 51 | ||
P/B | 4 | ||
P/E | -30 | ||
PEG | -1 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue